Ground breaking cancer immunotherapy research at the University of Surrey has received a massive boost thanks to two the Prostate Project and BRIGHT.
A strain of the common cold virus can infect and kill bladder cancer cells, a small study in the Clinical Cancer Research journal reports.
We have created a report for the Targeted Cancer Therapy Group at the University of Surrey.
Cancer immunotherapy is one of the newest and most promising of cancer treatments.
Some forms of cancer can become resistant to hormone therapy.
Clinical trials have found that the EN2 biomarker test is twice as effective as the PSA blood test currently used to detect prostate cancer.
Potential targets for novel therapies include proteins involved in cell growth and signalling within the cell.